LSIPR 50 2017: Andreas Peschel and Bernhard Krismer
Names: Andreas Peschel and Bernhard Krismer
Organisation: University of Tübingen
Positions: Researchers
Andreas Peschel and Bernhard Krismer discovered an antibiotic in the nose. The two scientists of the University of Tübingen in Germany found that Staphylococcus lugdunensis prevents the growth in the nasal cavity of Staphylococcus aureus, the bacteria which causes the antibiotic-resistant ‘superbug’ known as MRSA.
Peschel, who claims to have found a new concept of finding antibiotics, studied biology in Bochum and Tübingen, Germany, where he obtained a diploma and PhD degrees in microbiology.
He has been focusing on Staphylococcus aureus since he held postdoctoral positions in the laboratories of Friedrich Götz in Tübingen and Jos van Strijp in Utrecht, the Netherlands.
"Krismer has been a member of Peschel’s research group since 2008."
Peschel is professor of cellular and molecular microbiology in Tübingen, where has a special interest in teichoic acids, evasion of antimicrobial defence mechanisms, and proinflammatory bacterial molecules.
Krismer has been a member of Peschel’s research group since 2008. He studied biology in Innsbruck, Austria and Tübingen, where he obtained a diploma and PhD degrees in microbiology.
In 2002, he joined the company Dr Petry Genmedics as chief scientific officer and was responsible for contract research, development of large-scale protein expression and purification with a proprietary expression, as well as screening of natural product libraries.
Peschel and Krismer have said that their research adds weight to the idea that the human body itself could offer new possibilities in the fight against antibiotic resistance.
